Lupin Healthcare Acquires Renascience Pharma Limited (UK)
April 2, 2025
Lupin Healthcare (UK) Limited, a wholly owned subsidiary of Lupin Limited, has acquired UK-based Renascience Pharma Limited, the sole supplier of four specialty branded products in the UK. The acquisition (reported at approximately £12.3 million) expands Lupin's branded specialty portfolio in the UK and strengthens its supply offerings to the NHS across infectious disease, ENT and cardiology/renal indications.
- Buyers
- Lupin Healthcare (UK) Limited, Lupin Limited
- Targets
- Renascience Pharma Limited
- Industry
- Pharmaceuticals
- Location
- England, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Essential Pharma Acquires Renaissance Pharma Ltd
April 2, 2024
Pharmaceuticals
Essential Pharma has completed the acquisition of all issued share capital of Renaissance Pharma Ltd, gaining the clinical-stage immunotherapy Hu14.18K322A (Hu14.18) for treatment of high‑risk neuroblastoma. The deal adds a development‑stage rare disease oncology asset to Essential Pharma's portfolio; Renaissance's CEO Simon Ball and members of the Renaissance team will continue to work with Essential on further development in partnership with St. Jude Children's Research Hospital.
-
Mednow Inc. Acquires London Pharmacare Inc. and Liver Care Canada Inc.
February 23, 2022
Healthcare Services
Mednow Inc. completed the acquisitions of London Pharmacare Inc. and Liver Care Canada Inc., expanding its specialty pharmacy and clinical services footprint. The transactions (related-party in part) are expected to increase Mednow's patient base, add specialty physician relationships and integrate the targets into Mednow's technology and fulfillment operations.
-
Navitus Health Solutions Acquires EpiphanyRx; Lumicera Purchases Quality Drug Clinical Care
July 19, 2021
Healthcare Services
Navitus Health Solutions has acquired EpiphanyRx to broaden its PBM capabilities and mid-market employer reach. Its specialty pharmacy arm, Lumicera Health Services, also acquired Quality Drug Clinical Care in Irvine, California to expand Lumicera's specialty pharmacy footprint and HIV clinical services in the western United States.
-
PI Industries Acquires Plant Health Care Plc
November 24, 2025
Agriculture
In August 2024 PI Industries Ltd. acquired Plant Health Care Plc (PHC) and has integrated the business into its global agriculture arm, PI AgSciences. The acquisition expands PI's biologicals and sustainable crop solutions capabilities and brings PHC subsidiaries across the U.S., Brazil, Mexico and other markets into PI's global platform.
-
Lantheus Acquires Life Molecular Imaging from Life Healthcare
July 22, 2025
Healthcare Services
Lantheus Holdings, Inc. completed the acquisition of Life Molecular Imaging Ltd., a subsidiary of Life Healthcare Group Holdings Ltd., gaining the Neuraceq (florbetaben F18) commercial product, expanded Alzheimer’s radiodiagnostic infrastructure, and additional R&D capabilities. As part of the transaction, Dr. Ludger Dinkelborg (formerly CEO of Life Molecular) will join Lantheus as Head of Research & Development, reporting to the CEO.
-
Pfizer Acquires Biohaven Pharmaceutical Holding Company Ltd.
October 3, 2022
Pharmaceuticals
Pfizer Inc. completed the acquisition of Biohaven Pharmaceutical Holding Company Ltd. for approximately $11.6 billion (at $148.50 per share), bringing the migraine therapy NURTEC ODT (rimegepant), the zavegepant NDA program, and a CGRP-focused pipeline into Pfizer's Internal Medicine portfolio. Prior to closing, Biohaven spun off its non-CGRP assets into a separate publicly traded company, Biohaven Ltd., which Pfizer received a small pro rata stake in.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.